These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. The metabolic effects of insulin and rosiglitazone combination therapy in Chinese type 2 diabetic patients with nephropathy. Chan NN; Tong PC; So WY; Leung WY; Chiu CK; Chan JC Med Sci Monit; 2004 Mar; 10(3):PI44-8. PubMed ID: 14976448 [TBL] [Abstract][Full Text] [Related]
18. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan. Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302 [TBL] [Abstract][Full Text] [Related]
19. Variability of blood glucose levels in patients with type 1 diabetes mellitus on intensified insulin regimens. Moberg EA; Lins PE; Adamson UK Diabete Metab; 1994; 20(6):546-52. PubMed ID: 7713278 [TBL] [Abstract][Full Text] [Related]
20. Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients. Biesenbach G; Raml A; Schmekal B; Eichbauer-Sturm G Diabet Med; 2003 Aug; 20(8):642-5. PubMed ID: 12873291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]